Successful Treatment of Patients With Refractory PLA2R-Associated Membranous Nephropathy With Obinutuzumab: A Report of 3 Cases
- 1 December 2020
- journal article
- research article
- Published by Elsevier BV in American Journal of Kidney Diseases
- Vol. 76 (6), 883-888
- https://doi.org/10.1053/j.ajkd.2020.02.444
Abstract
No abstract availableFunding Information
- Genentech
This publication has 21 references indexed in Scilit:
- Neural epidermal growth factor-like 1 protein (NELL-1) associated membranous nephropathyKidney International, 2020
- Rituximab or Cyclosporine in the Treatment of Membranous NephropathyThe New England Journal of Medicine, 2019
- Exostosin 1/Exostosin 2-Associated Membranous NephropathyJournal of the American Society of Nephrology, 2019
- Thrombospondin Type-1 Domain-Containing 7A in Idiopathic Membranous NephropathyThe New England Journal of Medicine, 2014
- Treatment of idiopathic membranous nephropathyNature Reviews Nephrology, 2013
- Rituximab in Idiopathic Membranous NephropathyJournal of the American Society of Nephrology, 2012
- Rituximab Therapy in Idiopathic Membranous NephropathyClinical Journal of the American Society of Nephrology, 2010
- M-Type Phospholipase A2Receptor as Target Antigen in Idiopathic Membranous NephropathyThe New England Journal of Medicine, 2009
- A Randomized, Controlled Trial of Steroids and Cyclophosphamide in Adults with Nephrotic Syndrome Caused by Idiopathic Membranous NephropathyJournal of the American Society of Nephrology, 2007
- Idiopathic membranous nephropathy: Definition and relevance of a partial remissionKidney International, 2004